Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
Maria Gabriela DelgadoNando MertineitJaime BoschIris BaumgartnerAnnalisa BerzigottiPublished in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2024)
MELD-Na score, and sarcopenia were significantly associated with 1-year survival in cirrhotic patients who received TIPS.